Диссертация (1174258), страница 31
Текст из файла (страница 31)
Kitchen, D.G.T. Thomas // Br. Med. J. – 2000. – Т. 320. – № 7245. – С. 1322-1324.147. McGirt, M.J. Serum von Willebrand factor, matrix metalloproteinase-9,and vascular endothelial growth factor levels predict the onset of cerebral vasospasm182after aneurysmal subarachnoid hemorrhage / M.J. McGirt, J.R. Lynch, R. Blessing,D.S. Warner, A.H. Friedman, D.T. Laskowitz // Neurosurgery.
– 2002. – Т. 51. – №5. – С. 1128-1134.148. McGrath, R.T. Altered glycosylation of platelet-derived von Willebrandfactor confers resistance to ADAMTS13 proteolysis / R.T. McGrath, M. van denBiggelaar, B. Byrne, J.M. O’Sullivan, O. Rawley, R. O’Kennedy, J. Voorberg, R.J.S.Preston, J.S.
O’Donnell // Blood. – 2013. – Т. 122. – № 25. – С. 4107-4110.149. Meng, Z. Ectopic Expression of Human Angiopoietin-1 PromotesFunctional Recovery and Neurogenesis After Focal Cerebral Ischemia / Z. Meng, M.Li, Q. He, S. Jiang, X. Zhang, J. Xiao, Y. Bai // Neuroscience. – 2014. – Т.
267. – С.135-146.150. Michaux, G. P-selectin binds to the D ’-D3 domains of von Willebrandfactor in Weibel-Palade bodies / G. Michaux, T.J. Pullen, S.L. Haberichter, D.F.Cutler // Blood. – 2006. – Т. 107. – № 10. – С. 3922-3924.151. Mittal, M.K. Intracerebral Hemorrhage: Perihemorrhagic Edema andSecondary Hematoma Expansion: From Bench Work to Ongoing Controversies /M.K.
Mittal, A. LacKamp // Front. Neurol. – 2016. – Т. 7. – С. 210.152. Morgenstern, L.B. Guidelines for the Management of SpontaneousIntracerebral Hemorrhage A Guideline for Healthcare Professionals From theAmerican Heart Association/American Stroke Association / L.B. Morgenstern, J.C.Hemphill, C. Anderson, K. Becker, J.P. Broderick, E.S. Connolly, S.M.
Greenberg,J.N. Huang, R.L. Macdonald, S.R. Messe, P.H. Mitchell, M. Selim, R.J. Tamargo //Stroke. – 2010. – Т. 41. – № 9. – С. 2108-2129.153. Moschcowitz, E. Hyaline thrombosis of the terminal arterioles andcapillaries: a hitherto undescribed disease / E. Moschcowitz // Proc. N. Y. Pathol.Soc. – 1924. – Т. 24. – С. 21-24.154. Mozaffarian, D. Heart Disease and Stroke Statistics — 2016 Update. AReport From the American Heart Association / D. Mozaffarian, E.J. Benjamin, A.S.Go, D.K. Arnett, M.J. Blaha, M. Cushman, S.R.
Das, S. de Ferranti, J.-P. Despres,H.J. Fullerton, V.J. Howard, M.D. Huffman, C.R. Isasi, M.C. Jimenez, S.E. Judd,183B.M. Kissela, J.H. Lichtman, L.D. Lisabeth, S. Liu, R.H. Mackey, D.J. Magid, D.K.McGuire, E.R. Mohler, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W.Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, W.Rosamond, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, D. Woo, R.W.Yeh, M.B. Turner // Circulation. – 2016. – Т. 133. – № 4.
– С. E38-E360.155. Muchada, M. Baseline National Institutes of Health Stroke Scale-AdjustedTime Window for Intravenous Tissue-Type Plasminogen Activator in Acute IschemicStroke / M. Muchada, M. Rubiera, D. Rodriguez-Luna, J. Pagola, A. Flores, J. Kallas,E. Sanjuan, P. Meler, J. Alvarez-Sabin, M. Ribo, C.A. Molina // Stroke. – 2014. – Т.45. – № 4. – С. 1059-1063.156. Muia, J. Allosteric activation of ADAMTS13 by von Willebrand factor /J. Muia, J.
Zhu, G. Gupta, S. L. Haberichter, K.D. Friedman, H.B. Feys, L. Deforche,K. Vanhoorelbeke, L.A. Westfield, R. Rothe, N.H. Tolia, J.E. Heuser, J.E. Sadler //Proc. Natl. Acad. Sci. U.S.A. – 2014. – Т. 111. – № 52. – С. 18584-18589.157. Myers, M. Plasma Norepinephrine in Stroke / M. Myers, J. Norris, V.Hachinski, M. Sole // Stroke. – 1981. – Т. 12. – № 2. – С. 200-204.158. Nag, C. Prediction of Clinical Outcome in Acute Hemorrhagic Strokefrom a Single CT Scan on Admission. / C. Nag, K.
Das, M. Ghosh, M.R. Khandakar// North Am. J. Med. Sci. – 2012. – Т. 4. – № 10. – С. 463-467.159. Nakayama, T. Identification of amino acid residues responsible for vonWillebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis /T. Nakayama, T. Matsushita, K. Yamamoto, N. Mutsuga, T. Kojima, A.
Katsumi, N.Nakao, J.E. Sadler, T. Naoe, H. Saito // Int. J. Hematol. – 2008. – Т. 87. – № 4. – С.363-370.160. Nieswandt, B. Platelet-collagen interaction: is GPVI the central receptor?/ B. Nieswandt, S.P. Watson // Blood. – 2003. – Т. 102. – № 2. – С. 449-461.161. Nightingale, T. The secretion of von Willebrand factor from endothelialcells; an increasingly complicated story / T. Nightingale, D.
Cutler // J. Thromb.Haemost. – 2013. – Т. 11. – С. 192-201.184162. Nishio, K. Binding of platelet glycoprotein Ib alpha to von Willebrandfactor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13/ K. Nishio, P.J. Anderson, X.L. Zheng, J.E. Sadler // Proc. Natl. Acad. Sci. U.S.A.
–2004. – Т. 101. – № 29. – С. 10578-10583.163. O’Donnell, M.J. Risk factors for ischaemic and intracerebralhaemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-controlstudy / M.J. O’Donnell, D. Xavier, L. Liu, H. Zhang, S.L. Chin, P. Rao-Melacini, S.Rangarajan, S. Islam, P. Pais, M.J. McQueen, C. Mondo, A. Damasceno, P. LopezJaramillo, G.J. Hankey, A.L.
Dans, K. Yusoff, T. Truelsen, H.-C. Diener, R.L. Sacco,D. Ryglewicz, A. Czlonkowska, C. Weimar, X. Wang, S. Yusuf // Lancet. – 2010. –Т. 376. – № 9735. – С. 112-123.164. Ogata, T. Deep venous thrombosis after acute intracerebral hemorrhage /T. Ogata, M. Yasaka, Y. Wakugawa, T. Inoue, S. Ibayashi, Y. Okada // J. Neurol.Sci. – 2008. – Т. 272. – № 1-2.
– С. 83-86.165. Oh, Y.M. Synthesis and characterization of insulin-like growth factorbinding protein (IGFBP)-7 - Recombinant human mac25 protein specifically bindsIGF-I and II / Y.M. Oh, S.R. Nagalla, Y. Yamanaka, H.S. Kim, E. Wilson, R.G.Rosenfeld // J. Biol. Chem. – 1996. – Т. 271. – № 48. – С. 30322-30325.166. Olson, J. Evaluation of Ristocetin-Willebrand Factor Assay andRistocetin-Induced Platelet-Aggregation / J. Olson, W.
Brockway, D. Fass, M.Magnuson, E. Bowie // Am. J. Clin. Pathol. – 1975. – Т. 63. – № 2. – С. 210-218.167. O’Sullivan, J.M. Galectin-1 and Galectin-3 Constitute Novel-BindingPartners for Factor VIII / J.M. O’Sullivan, P.V. Jenkins, O. Rawley, K. Gegenbauer,A. Chion, M. Lavin, B. Byrne, R.
O’Kennedy, R.J.S. Preston, T.M. Brophy, J.S.O’Donnell // Arterioscler. Thromb. Vasc. Biol. – 2016. – Т. 36. – № 5. – С. 855-863.168. Ozaka, T. Weibel-Palade bodies as a storage site of calcitonin generelated peptide and endothelin-1 in blood vessels of the rat carotid body / T. Ozaka,Y. Doi, K.
Kayashima, S. Fujimoto // Anat. Rec. – 1997. – Т. 247. – № 3. – С. 388394.185169. Parker, D.N. The functions of the A1A2A3 domains in von Willebrandfactor include multimerin 1 binding / D.N. Parker, S. Tasneem, R.W. Farndale, D.Bihan, J.E. Sadler, S. Sebastian, P.G. De Groot, C.P.M. Hayward // Thromb.Haemost.
– 2016. – Т. 116. – № 1. – С. 87-95.170. Pegon, J.N. Factor VIII and von Willebrand factor are ligands for thecarbohydrate-receptor Siglec-5 / J.N. Pegon, M. Kurdi, C. Casari, S. Odouard, C.V.Denis, O.D. Christophe, P.J. Lenting // Hematol. J. – 2012. – Т. 97. – № 12. – С.1855-1863.171. Pendu, R. P-selectin glycoprotein ligand 1 and beta 2-integrins cooperatein the adhesion of leukocytes to von Willebrand factor / R.
Pendu, V. Terraube, O.D.Christophe, C.G. Gahmberg, P.G. de Groot, P. J. Lenting, C.V. Denis // Blood. –2006. – Т. 108. – № 12. – С. 3746-3752.172. Pi, L. CCN2/CTGF regulates neovessel formation via targetingstructurally conserved cystine knot motifs in multiple angiogenic regulators / L. Pi,A.K. Shenoy, J. Liu, S. Kim, N. Nelson, H. Xia, W.W. Hauswirth, B.E. Petersen,G.S.
Schultz, E.W. Scott // Faseb J. – 2012. – Т. 26. – № 8. – С. 3365-3379.173. Pozzi, N. Modeling ADAMTS13-von Willebrand Factor interaction:Implications for oxidative stress-related cardiovascular diseases and type 2A vonWillebrand Disease / N. Pozzi, S. Lancellotti, R. De Cristofaro, V. De Filippis //Biophys. Chem. – 2012. – Т. 160. – № 1. – С. 1-11.174. Pusch, G. Early Dynamics of P-selectin and Interleukin 6 PredictsOutcomes in Ischemic Stroke / G. Pusch, B.
Debrabant, T. Molnar, G. Feher, V.Papp, M. Banati, N. Kovacs, L. Szapary, Z. Illes // J. Stroke Cerebrovasc. Dis. –2015. – Т. 24. – № 8. – С. 1938-1947.175. Qin, F. Overexpression of von Willebrand factor is an independent riskfactor for pathogenesis of intimal hyperplasia: Preliminary studies / F. Qin, T.Impeduglia, P. Schaffer, H. Dardik // J. Vasc. Surg. – 2003. – Т. 37. – № 2. – С. 433439.186176. Quinones-Hinojosa, A. Spontaneous intracerebral hemorrhage due tocoagulation disorders. / A. Quinones-Hinojosa, M. Gulati, V. Singh, M. T. Lawton //Neurosurg. Focus. – 2003. – Т. 15.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
